Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORAL: Cancer of the Ovary Abiraterone Trial
ISRCTN63407050Phase 2Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of abiraterone, prednisone and prednisolone in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC), sponsored by The Institute of Cancer Research. Primary endpoint: Clinical activity / objective response rate. Started Jul 2013; status: completed.
02
Drugs
abirateroneprednisoneprednisolone
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on ISRCTN63407050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63407050.